GLUPERB Trademark

Trademark Overview

On Friday, September 9, 2005, a trademark application was filed for GLUPERB with the United States Patent and Trademark Office. The USPTO has given the GLUPERB trademark a serial number of 78709660. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 2, 2009. This trademark is owned by Bristol-Myers Squibb Company. The GLUPERB trademark is filed in the Pharmaceutical Products category with the following description:

Medical imaging and contrast media, namely, reagents, diagnostic preparations for medical use, diagnostic imaging agents, radiopharmaceutical diagnostic imaging agents, contrast media for use in medical imaging
gluperb

General Information

Serial Number78709660
Word MarkGLUPERB
Filing DateFriday, September 9, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 2, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2007

Trademark Statements

Goods and ServicesMedical imaging and contrast media, namely, reagents, diagnostic preparations for medical use, diagnostic imaging agents, radiopharmaceutical diagnostic imaging agents, contrast media for use in medical imaging
Pseudo MarkGLUE SUPERB

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, November 2, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 2, 2009ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 4, 2009EXTENSION 4 GRANTED
Wednesday, February 4, 2009EXTENSION 4 FILED
Wednesday, February 4, 2009TEAS EXTENSION RECEIVED
Wednesday, August 13, 2008EXTENSION 3 GRANTED
Wednesday, August 13, 2008EXTENSION 3 FILED
Wednesday, August 13, 2008TEAS EXTENSION RECEIVED
Sunday, February 10, 2008EXTENSION 2 GRANTED
Sunday, February 10, 2008EXTENSION 2 FILED
Sunday, February 10, 2008TEAS EXTENSION RECEIVED
Friday, September 14, 2007EXTENSION 1 GRANTED
Friday, September 14, 2007EXTENSION 1 FILED
Friday, September 14, 2007TEAS EXTENSION RECEIVED
Wednesday, May 23, 2007ASSIGNED TO EXAMINER
Tuesday, March 27, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 2, 2007PUBLISHED FOR OPPOSITION
Wednesday, December 13, 2006NOTICE OF PUBLICATION
Monday, November 13, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 9, 2006ASSIGNED TO LIE
Tuesday, November 7, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 6, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 2, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 2, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 2, 2006PETITION TO REVIVE-GRANTED
Thursday, November 2, 2006TEAS PETITION TO REVIVE RECEIVED
Thursday, October 19, 2006ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 19, 2006ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, March 23, 2006PRIORITY ACTION MAILED
Wednesday, March 22, 2006PRIORITY ACTION WRITTEN
Tuesday, March 21, 2006ASSIGNED TO EXAMINER
Friday, September 16, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

gluperb imaging diagnostic medical media agents contrast radiopharmaceutical namely reagents preparations